Applied Molecular Transport Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 126.33 million compared to USD 100.29 million a year ago. Basic loss per share from continuing operations was USD 3.25 compared to USD 2.67 a year ago.
Applied Molecular Transport Inc.
Equities
AMTI
US03824M1099
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+21.51% | 46.93B | |
+37.63% | 39.08B | |
-8.42% | 38.48B | |
+29.12% | 31.01B | |
-13.75% | 26.14B | |
+11.12% | 25.88B | |
+35.97% | 12.53B | |
-6.66% | 11.36B | |
-12.44% | 10.65B |